A carregar...

CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis.

CI-960 is a new fluoroquinolone with enhanced in vitro activity against gram-positive pathogens. The efficacy of the drug was compared with that of vancomycin by using the rabbit model of nafcillin- and ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis. Animals received int...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kaatz, G W, Seo, S M, Lamp, K C, Bailey, E M, Rybak, M J
Formato: Artigo
Idioma:Inglês
Publicado em: 1992
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC190313/
https://ncbi.nlm.nih.gov/pubmed/1329613
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!